Literature DB >> 26722537

Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.

Peng Li1, Fan Wu1, Hong Zhao1, Lizhou Dou1, Yang Wang1, Chunguang Guo1, Guiqi Wang1, Dongbing Zhao1.   

Abstract

OBJECTIVE: To analyze the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors after surgical treatment.
METHODS: A retrospective analysis was conducted using the clinical data from 156 cases of rectal neuroendocrine tumors during the period of January 1999 to December 2013. The Kaplan-Meier method was used to calculate the survival time, Cox regression analysis was performed for statistical analysis of clinicopathological factors that may be associated with lymph node metastasis and prognosis, and correlation analysis was carried out using binary logistic regression.
RESULTS: The overall 5-year survival rate of the entire group was 95.7%. Multivariate analysis showed that the depth of invasion was an independent prognostic factor (P < 0.001). The incidence of lymph node metastasis was 7.7% (12/156), and logistic regression analysis showed that lymph node metastasis was related to the depth of invasion (P = 0.003) and tumor diameter (P = 0.006).
CONCLUSION: The surgical approach of rectal neuroendocrine tumors should be selected based on a comprehensive consideration of factors such as tumor size, depth of invasion and lymph node metastasis.

Entities:  

Keywords:  Neuroendocrine tumors; lymph node metastasis; rectal neuroendocrine

Mesh:

Year:  2015        PMID: 26722537      PMCID: PMC4680482     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Carcinoid tumors of the rectum: a multi-institutional international collaboration.

Authors:  Conor J Shields; Emmanuel Tiret; Desmond C Winter
Journal:  Ann Surg       Date:  2010-11       Impact factor: 12.969

2.  Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.

Authors:  Yihebali Chi; Feng Du; Hong Zhao; Jin-Wan Wang; Jian-Qiang Cai
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 3.  Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

Authors:  R Garcia-Carbonero; J Capdevila; G Crespo-Herrero; J A Díaz-Pérez; M P Martínez Del Prado; V Alonso Orduña; I Sevilla-García; C Villabona-Artero; A Beguiristain-Gómez; M Llanos-Muñoz; M Marazuela; C Alvarez-Escola; D Castellano; E Vilar; P Jiménez-Fonseca; A Teulé; J Sastre-Valera; M Benavent-Viñuelas; A Monleon; R Salazar
Journal:  Ann Oncol       Date:  2010-02-05       Impact factor: 32.976

Review 4.  Carcinoids of the rectum: an evaluation of 1271 reported cases.

Authors:  J Soga
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

5.  Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors.

Authors:  Christine S Landry; Keith Cavaness; Scott Celinski; John Preskitt
Journal:  Gland Surg       Date:  2014-11

6.  Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Authors:  Tetsuhide Ito; Hironobu Sasano; Masao Tanaka; R Yoshiyuki Osamura; Iwao Sasaki; Wataru Kimura; Koji Takano; Takao Obara; Miyuki Ishibashi; Kazuwa Nakao; Ryuichiro Doi; Akira Shimatsu; Toshirou Nishida; Izumi Komoto; Yukio Hirata; Kazuhiko Nakamura; Hisato Igarashi; Robert T Jensen; Bertram Wiedenmann; Masayuki Imamura
Journal:  J Gastroenterol       Date:  2010-02       Impact factor: 7.527

7.  Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems.

Authors:  Ryaz Chagpar; Yi-Ju Chiang; Yan Xing; Janice N Cormier; Barry W Feig; Asif Rashid; George J Chang; Y Nancy You
Journal:  Ann Surg Oncol       Date:  2012-12-01       Impact factor: 5.344

8.  A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies.

Authors:  Anna Fen-Yau Li; Chih-Yi Hsu; Alice Li; Ling-Chen Tai; Wen-Yih Liang; Win-Yin Li; Shyh-Haw Tsay; Jeou-Yuan Chen
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

9.  Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.

Authors:  Shunsuke Tsukamoto; Shin Fujita; Tomohiro Yamaguchi; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya; Hirokazu Taniguchi; Tadakazu Shimoda
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

10.  Clinical and prognostic features of rectal neuroendocrine tumors.

Authors:  Brett Weinstock; Stephen C Ward; Noam Harpaz; Richard R P Warner; Steven Itzkowitz; Michelle Kang Kim
Journal:  Neuroendocrinology       Date:  2013-11-05       Impact factor: 4.914

View more
  15 in total

Review 1.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

2.  A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.

Authors:  Adriana C Gamboa; Yuan Liu; Rachel M Lee; Mohammad Y Zaidi; Charles A Staley; Maria C Russell; Kenneth Cardona; Patrick S Sullivan; Shishir K Maithel
Journal:  J Surg Oncol       Date:  2019-08-26       Impact factor: 3.454

Review 3.  Rectal neuroendocrine neoplasms: what the radiologists should know.

Authors:  Mayur Virarkar; Dheeraj R Gopireddy; Ajaykumar C Morani; Ahmad Alkhasawneh; Sergio Piotr Klimkowski; Sindhu Kumar; Chandana Lall; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2022-03-14

Review 4.  Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs).

Authors:  Francesco Maione; Alessia Chini; Marco Milone; Nicola Gennarelli; Michele Manigrasso; Rosa Maione; Gianluca Cassese; Gianluca Pagano; Francesca Paola Tropeano; Gaetano Luglio; Giovanni Domenico De Palma
Journal:  Diagnostics (Basel)       Date:  2021-04-25

5.  HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis.

Authors:  Fang-Teng Liu; Yang-Xi Ou; Guan-Ping Zhang; Cheng Qiu; Hong-Liang Luo; Pei-Qian Zhu
Journal:  Onco Targets Ther       Date:  2016-05-06       Impact factor: 4.147

6.  The microRNA miR-10b as a potentially promising biomarker to predict the prognosis of cancer patients: a meta-analysis.

Authors:  Yi Zhang; Rong-Bo Liao; Li-Lin Hu; Bi-Xia Tong; Teng-Fei Hao; Hua-Jun Wu
Journal:  Oncotarget       Date:  2017-09-30

7.  Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.

Authors:  Yang-Hua Fan; Miao-Jing Wu; Yuan Jiang; Minhua Ye; Shi-Gang Lu; Lei Wu; Xin-Gen Zhu
Journal:  Oncotarget       Date:  2017-03-28

Review 8.  BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis.

Authors:  Yang-Hua Fan; Min-Hua Ye; Lei Wu; Miao-Jing Wu; Shi-Gang Lu; Xin-Gen Zhu
Journal:  Oncotarget       Date:  2017-01-24

9.  Nomogram for individually predicting overall survival in rectal neuroendocrine tumours.

Authors:  Xingyu Feng; Gengzhou Wei; Wei Wang; Yu Zhang; Yujie Zeng; Minhu Chen; Ye Chen; Jie Chen; Zhiwei Zhou; Yong Li
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

10.  Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis.

Authors:  Peng-Ju Ma; Qing-Kai Guan; Lei Meng; Nan Qin; Jia Zhao; Bao-Zhe Jin
Journal:  Oncotarget       Date:  2017-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.